Ndwm LLC Makes New $1.46 Million Investment in iShares Biotechnology ETF $IBB

Ndwm LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, Holdings Channel.com reports. The fund purchased 6,931 shares of the financial services provider’s stock, valued at approximately $1,459,000. iShares Biotechnology ETF makes up 0.8% of Ndwm LLC’s investment portfolio, making the stock its 23rd largest holding.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Bank of America Corp DE raised its stake in shares of iShares Biotechnology ETF by 10.8% in the 1st quarter. Bank of America Corp DE now owns 7,259,501 shares of the financial services provider’s stock valued at $1,225,767,000 after buying an additional 707,343 shares in the last quarter. Royal Bank of Canada lifted its holdings in shares of iShares Biotechnology ETF by 1.0% during the 1st quarter. Royal Bank of Canada now owns 737,128 shares of the financial services provider’s stock worth $124,464,000 after acquiring an additional 7,434 shares during the period. Jefferies Financial Group Inc. lifted its holdings in shares of iShares Biotechnology ETF by 38.1% during the 3rd quarter. Jefferies Financial Group Inc. now owns 417,500 shares of the financial services provider’s stock worth $87,896,000 after acquiring an additional 115,194 shares during the period. Commonwealth Equity Services LLC boosted its position in shares of iShares Biotechnology ETF by 1.3% during the 3rd quarter. Commonwealth Equity Services LLC now owns 139,653 shares of the financial services provider’s stock valued at $29,401,000 after acquiring an additional 1,819 shares in the last quarter. Finally, Cetera Investment Advisers boosted its position in shares of iShares Biotechnology ETF by 9.4% during the 1st quarter. Cetera Investment Advisers now owns 128,530 shares of the financial services provider’s stock valued at $21,702,000 after acquiring an additional 10,994 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.4%

Shares of iShares Biotechnology ETF stock opened at $218.14 on Thursday. The firm’s 50-day simple moving average is $208.98 and its 200-day simple moving average is $186.54. iShares Biotechnology ETF has a twelve month low of $159.68 and a twelve month high of $222.29.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 18th. Shareholders of record on Tuesday, September 15th were paid a dividend of $0.0112 per share. This is a negative change from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 dividend on an annualized basis and a yield of 0.0%. The ex-dividend date was Tuesday, September 15th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.